314 related articles for article (PubMed ID: 25815766)
1. Gut microbiota and tacrolimus dosing in kidney transplantation.
Lee JR; Muthukumar T; Dadhania D; Taur Y; Jenq RR; Toussaint NC; Ling L; Pamer E; Suthanthiran M
PLoS One; 2015; 10(3):e0122399. PubMed ID: 25815766
[TBL] [Abstract][Full Text] [Related]
2. Optimal immunosuppressor induces stable gut microbiota after liver transplantation.
Jiang JW; Ren ZG; Lu HF; Zhang H; Li A; Cui GY; Jia JJ; Xie HY; Chen XH; He Y; Jiang L; Li LJ
World J Gastroenterol; 2018 Sep; 24(34):3871-3883. PubMed ID: 30228781
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients.
Lee JR; Magruder M; Zhang L; Westblade LF; Satlin MJ; Robertson A; Edusei E; Crawford C; Ling L; Taur Y; Schluter J; Lubetzky M; Dadhania D; Pamer E; Suthanthiran M
Am J Transplant; 2019 Feb; 19(2):488-500. PubMed ID: 29920927
[TBL] [Abstract][Full Text] [Related]
4. Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites.
Guo Y; Crnkovic CM; Won KJ; Yang X; Lee JR; Orjala J; Lee H; Jeong H
Drug Metab Dispos; 2019 Mar; 47(3):194-202. PubMed ID: 30598508
[TBL] [Abstract][Full Text] [Related]
5. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study.
Lee JR; Huang J; Magruder M; Zhang LT; Gong C; Sholi AN; Albakry S; Edusei E; Muthukumar T; Lubetzky M; Dadhania DM; Taur Y; Pamer EG; Suthanthiran M
Transpl Infect Dis; 2019 Dec; 21(6):e13180. PubMed ID: 31544324
[TBL] [Abstract][Full Text] [Related]
6. Gut microbial community structure and complications after kidney transplantation: a pilot study.
Lee JR; Muthukumar T; Dadhania D; Toussaint NC; Ling L; Pamer E; Suthanthiran M
Transplantation; 2014 Oct; 98(7):697-705. PubMed ID: 25289916
[TBL] [Abstract][Full Text] [Related]
7. Gut commensal microbiota and decreased risk for
Magruder M; Edusei E; Zhang L; Albakry S; Satlin MJ; Westblade LF; Malha L; Sze C; Lubetzky M; Dadhania DM; Lee JR
Gut Microbes; 2020 Nov; 12(1):1805281. PubMed ID: 32865119
[TBL] [Abstract][Full Text] [Related]
8. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].
Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005
[TBL] [Abstract][Full Text] [Related]
9. The Alteration human of gut microbiota and metabolites before and after renal transplantation.
Yu DH; Ying N; Lian ZH; Fa YQ
Microb Pathog; 2021 Nov; 160():105191. PubMed ID: 34571151
[TBL] [Abstract][Full Text] [Related]
10. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
11. Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium?
Ding C; Xue W; Tian P; Ding X; Pan X; Xiang H; Tian X; Li Y; Zheng J
Int J Clin Pract Suppl; 2014 Apr; (181):10-6. PubMed ID: 24673714
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study.
Degraeve AL; Bindels LB; Haufroid V; Moudio S; Boland L; Delongie KA; Dewulf JP; Eddour DC; Mourad M; Elens L
Clin Pharmacol Ther; 2024 Jan; 115(1):104-115. PubMed ID: 37846607
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients.
Westblade LF; Satlin MJ; Albakry S; Botticelli B; Robertson A; Alston T; Magruder M; Zhang LT; Edusei E; Chan K; Lubetzky M; Dadhania DM; Pamer EG; Suthanthiran M; Lee JR
Transpl Infect Dis; 2019 Dec; 21(6):e13167. PubMed ID: 31502737
[TBL] [Abstract][Full Text] [Related]
14. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota profiles and fecal beta-glucuronidase activity in kidney transplant recipients with and without post-transplant diarrhea.
Zhang LT; Westblade LF; Iqbal F; Taylor MR; Chung A; Satlin MJ; Magruder M; Edusei E; Albakry S; Botticelli B; Robertson A; Alston T; Dadhania DM; Lubetzky M; Hirota SA; Greenway SC; Lee JR
Clin Transplant; 2021 May; 35(5):e14260. PubMed ID: 33605497
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.
Liu LS; Li J; Chen XT; Zhang HX; Fu Q; Wang HY; Xiong YY; Liu S; Liu XM; Li JL; Huang M; Wang CX
Int J Clin Pract Suppl; 2015 May; (183):43-52. PubMed ID: 26177348
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
18. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
[TBL] [Abstract][Full Text] [Related]
19. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study.
Størset E; Åsberg A; Skauby M; Neely M; Bergan S; Bremer S; Midtvedt K
Transplantation; 2015 Oct; 99(10):2158-66. PubMed ID: 25886918
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant Tacrolimus Dose Requirements Predict Early Posttransplant Dose Requirements in Blood Group AB0-Incompatible Kidney Transplant Recipients.
Shuker N; de Man FM; de Weerd AE; van Agteren M; Weimar W; Betjes MG; van Gelder T; Hesselink DA
Ther Drug Monit; 2016 Apr; 38(2):217-22. PubMed ID: 26630539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
